Latest debt-to-equity ratio
ABVC BioPharma Debt-to-equity ratio
Direct answer
ABVC BioPharma's debt-to-equity ratio is 23.53%.
The verified market snapshot reports 23.53%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free ABVC BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 23.53%
Explore related company data
View ABVC BioPharma's market capitalizationView ABVC BioPharma's price-to-book ratioView ABVC BioPharma's return on equityView ABVC BioPharma's dividend yieldView ABVC BioPharma's 52-week price rangeView ABVC BioPharma's profit marginView all ABVC BioPharma key metricsReturn to ABVC BioPharma profile